CMS Efforts to Lower Drug Costs for Part D Stakeholders Aided by HealthTech On August 28, the Centers for Medicare & Medicaid Services (CMS), the
Medicare Part D is the pharmacy benefit for people on Medicare. It is an essential program giving older populations access to life-saving medications. However, a
In a nation where modern medicine has made remarkable strides, the fact that high prescription prices force people to disregard doctor’s orders is a profoundly
Prescription drug abuse is a pressing public health concern because of the devastating consequences for individuals, families, and communities. Misuse of prescription drugs leads to
The CDC recently released a study that directly ties the cost of medication with nonadherence and poorer health outcomes. The study “Characteristics of Adults Aged
AUSTIN, Texas, July 12, 2023 /PRNewswire/ — Tom Dorsett, CEO of RazorMetrics wins the prestigious Merit Award for Business Leadership. RazorMetrics is an Austin-based drug cost-reduction platform for health plans, large
The Centers for Medicare and Medicaid Services (CMS) is proposing a change to self-funded small employers that could roll back some of these protections and undermine state insurance oversight.
RazorMetrics, an Austin-based drug cost reduction platform, has once again won the “Best Places to Work” award from the Austin Business Journal.
The annual award is only given to those companies that demonstrably go above and beyond to develop and reward employees. Companies are only eligible for the award if they are nominated and supported by their employees.
A recent study conducted by the CDC, titled “Characteristics of Adults Aged 18–64 Who Did Not Take Medication as Prescribed to Reduce Costs: United States, 2021,” delves into the factors influencing medication nonadherence due to financial constraints.
In the world of healthcare, optimizing medication costs while ensuring patient well-being is a delicate balance. RazorMetrics, a leading healthcare technology company, is revolutionizing this process by facilitating prescription switches through effective communication between prescribers, patients, and pharmacists. Leveraging our proprietary Intervention Codex, we provide cost-effective, therapeutically equivalent alternatives and improve healthcare affordability without compromising quality.
And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.
